Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fortress Biotech (FBIO) Long-Term Debt Issuances (2016 - 2024)

Historic Long-Term Debt Issuances for Fortress Biotech (FBIO) over the last 11 years, with Q4 2024 value amounting to -$33.7 million.

  • Fortress Biotech's Long-Term Debt Issuances fell 22042.14% to -$33.7 million in Q4 2024 from the same period last year, while for Sep 2024 it was $61.7 million, marking a year-over-year increase of 113436.0%. This contributed to the annual value of $28.0 million for FY2023, which is 46000.0% up from last year.
  • As of Q4 2024, Fortress Biotech's Long-Term Debt Issuances stood at -$33.7 million, which was down 22042.14% from $33.7 million recorded in Q3 2024.
  • In the past 5 years, Fortress Biotech's Long-Term Debt Issuances ranged from a high of $42.1 million in Q1 2022 and a low of -$42.1 million during Q2 2022
  • Its 4-year average for Long-Term Debt Issuances is $4.4 million, with a median of $7.0 million in 2021.
  • As far as peak fluctuations go, Fortress Biotech's Long-Term Debt Issuances skyrocketed by 46000.0% in 2023, and later crashed by 22042.14% in 2024.
  • Fortress Biotech's Long-Term Debt Issuances (Quarter) stood at $7.0 million in 2021, then fell by 28.57% to $5.0 million in 2022, then surged by 460.0% to $28.0 million in 2023, then tumbled by 220.42% to -$33.7 million in 2024.
  • Its Long-Term Debt Issuances was -$33.7 million in Q4 2024, compared to $33.7 million in Q3 2024 and $28.0 million in Q4 2023.